Tag: clinical

Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.Avance Clinical has undergone significant expansion in recent years, including new offices in Sydney and Melbourne to accommodate the growing clinical team in Australia. The award winner will be announced on 1 September 2022. The finalists are:– Avance Clinical– Calyx– CMIC Group– EPS– ICON– Parexel– Syneos Health Avance Clinical’s CEO Yvonne Lungershausen said: “Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is ... Read more

 Clinical PURSUIT has leveraged Enterprise Solutions to optimize data integration and flow in their Electronic Data Capture Software (EDC). Enterprise Solutions use privately hosted server environments with redundancy for data storage, making it easier to organize data access and operations management. By incorporating their advanced enterprise solutions into their EDC software, Clinical PURSUIT has converted its EDC into an EDC-CTMS (Clinical Trial Management Software) hybrid. The reason is that the software can now access trial schedules, drug supply information, treatment plans, etc., match them to data capture, and automatically update fields with relevant information. These intelligent data transfers and updates ... Read more

Since February 2020, when Suntrap Life Technologies Ltd established a COVID-19 project for drug discovery, the Suntrap research team has evaluated and prudently predicted the characteristics of COVID-19. Utilizing the proprietary S-CPDD drug design and discovery system and IDDNU(R) (International Drug Design Network Union) platforms in accordance with scientific laws of drug discovery, Suntrap’s research team has tracked and analyzed the pathological characteristics, clinical needs, pathogenesis research and social demands of patients. In terms of the determination of the direction of drug research and development (R&D), COVID-19 drug related targets acquisition, molecular design and screening, and preclinical verification, the new ... Read more

Eisai Co., Ltd. and Biogen Inc. announced today results of sensitivity analyses evaluating the consistency of lecanemab efficacy results across multiple statistical models in patients with Mild Cognitive Impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD). This presentation was made by Eisai at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) conference, November 9-12, 2021 in Boston, Massachusetts and virtually. In September 2021, Eisai initiated a rolling submission of a Biologics License Application (BLA) for lecanemab, an investigational anti-amyloid beta protofibril antibody, for the treatment of early AD, to the U.S. Food and ... Read more

The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial.Tetherex Pharmaceuticals, Inc. is a privately held, clinical stage biopharmaceutical company focused on development of selectin inhibitor therapeutics for the treatment of a broad range of inflammatory diseases and single-cycle adenovirus vaccines for multiple infectious diseases and cancer indications. Avance Clinical Chief Scientific Officer Dr Gabriel Kremmidiotis said: “The exciting aspect of the Tetherex product is the potential to vaccinate using a nasal spray. Administering ... Read more